WEN Attorneys Meet With Top FDA Officials In ‘Continued Cooperation’
This article was originally published in The Rose Sheet
Executive Summary
CFSAN Director Susan Mayne and other high-level FDA officials met with Guthy-Renker and WEN leadership and outside attorneys in September. The substance of the meeting is being kept under wraps, but it shows FDA’s continued involvement in the WEN issue, which drove discussion at the recent Senate HELP Committee hearing on cosmetics.